Report

MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

See allHide authors and affiliations

Science  18 May 2007:
Vol. 316, Issue 5827, pp. 1039-1043
DOI: 10.1126/science.1141478

Log in to view Figures & Data

Log in through your institution

Log in through your institution